Evaluating voice outcomes after gender-affirming voice surgeries

Voice Outcome of Glottoplasty, Cricothyroid Approximation, Thyroplasty, and Chondrolaryngoplasty

Not applicable Interventional University Ghent · NCT06439290

This study is testing how different gender-affirming voice surgeries affect voice quality and patient satisfaction over time.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment290 (estimated)
Ages18 Years to 70 Years
SexAll
SponsorUniversity Ghent Academic / other
Locations2 sites (Ghent, East-Flanders and 1 other locations)
Trial IDNCT06439290 on ClinicalTrials.gov

What this trial studies

This study aims to assess the short- and long-term voice outcomes of various gender-affirming surgeries, including glottoplasty, cricothyroid approximation, thyroplasty, and chondrolaryngoplasty. It employs a prospective non-randomized controlled trial design and utilizes a multidimensional voice assessment protocol. Additionally, a laryngeal MRI protocol will be developed to analyze pre- and postoperative anatomical factors and their correlation with acoustic changes in voice. The study will also evaluate the impact of these surgeries on voice characteristics, psychosocial well-being, and patient satisfaction.

Who should consider this trial

Good fit: Ideal candidates include individuals aged 18 and older who are scheduled to undergo voice-related surgeries at UZ Gent and have a sufficient command of the Dutch language.

Not a fit: Patients who do not speak Dutch or have contraindications for MRI examinations may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could enhance the understanding of voice outcomes for transgender and gender-diverse individuals undergoing voice surgeries, leading to improved surgical techniques and patient satisfaction.

How similar studies have performed: While there have been studies on voice outcomes in transgender individuals, this specific combination of interventions and methodologies is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
PURPOSE 1:

Inclusion criteria for surgery participants:

* Persons who will soon undergo surgery on the vocal folds and/or larynx (including glottoplasty, cricothyroid approximation, thyroplasty and/or thyroid chondroplasty) at UZ Gent
* At least 18 years old
* Sufficient command of the Dutch language for understanding the informed consent letter and completing Dutch questionnaires

Inclusion criteria for volunteers to provide speech samples:

\- Cisgender men or women

Inclusion criteria for volunteer listeners for the listening experiment:

* Dutch-speaking
* Self-reported normal hearing

PURPOSE 2: same as above.

PURPOSE 3:

Inclusion criteria for the healthy participants:

* At least 18 years old
* Sufficient command of the Dutch language to complete a Dutch questionnaire

Exclusion criteria for the healthy participants:

\- One or more contraindications for an MRI examination. These contraindications are checked using a questionnaire (safety checklist).

Inclusion criteria for the pre- and postoperative MRI participants:

\- Random selection of +- 10 participants of purpose 1.

Exclusion criteria for the pre- and postoperative MRI participants:

\- One or more contraindications for an MRI examination. These contraindications are checked using a questionnaire (safety checklist).

Where this trial is running

Ghent, East-Flanders and 1 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions SurgeryLarynxTransgenderismGender DysphoriaTransgenderPhonosurgeryDeterminantsMRI
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.